Characterizing Response to PARP Inhibitor Treatment Combinations in Advanced Prostate Cancer.
- DOI
- 10.3390/biomedicines14050949
- Published
- 2026 Apr 22
- Container
- Biomedicines
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3390/biomedicines14050949,
title = {Characterizing Response to PARP Inhibitor Treatment Combinations in Advanced Prostate Cancer.},
author = {Correa Gonzalez B and Karthikeyan A and Moore LA and Bhaumik A and Sandoval E and Hardy M and McPherson JD and Li H and Parikh M and Dall'Era M and Gao AC and Lombard AP},
year = {2026},
journal = {Biomedicines},
doi = {10.3390/biomedicines14050949},
url = {https://doi.org/10.3390/biomedicines14050949}
}RIS
TY - JOUR TI - Characterizing Response to PARP Inhibitor Treatment Combinations in Advanced Prostate Cancer. AU - Correa Gonzalez B AU - Karthikeyan A AU - Moore LA AU - Bhaumik A AU - Sandoval E AU - Hardy M AU - McPherson JD AU - Li H AU - Parikh M AU - Dall'Era M AU - Gao AC AU - Lombard AP PY - 2026 JO - Biomedicines DO - 10.3390/biomedicines14050949 UR - https://doi.org/10.3390/biomedicines14050949 ER -
APA
B, C. G., A, K., LA, M., A, B., E, S., M, H., JD, M., H, L., M, P., M, D., AC, G., & AP, L. (2026). Characterizing Response to PARP Inhibitor Treatment Combinations in Advanced Prostate Cancer.. Biomedicines. https://doi.org/10.3390/biomedicines14050949
Source records
- pubmed · retrieved 2026-09-27T10:04:35.334Z